Abstract
Ventricular arrhythmias may occur in cardiomyopathies, with often fatal consequences. Arrhythmias can occur during physical activity with sympathetic activation, for example, in the case of arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D), or at rest with parasympathetic activation, for example, in patients with Brugada syndrome. Medication with effect on the autonomous nervous system, most notably β-receptor blockers, can modulate the disease manifestations associated with arrhythmias such as syncopes. There is a strong clinical need to identify the optimal treatment strategy in a personalized manner. Molecular imaging of the autonomous nervous system may add valuable additional information. Radiopharmaceuticals targeting the presynaptic and postsynaptic portions of the sympathetic system for use with single-photon emission computed tomography (SPECT) and positron-emission tomography (PET) have seen the most widespread application; studies also targeting the parasympathetic function have started to appear. This chapter provides an overview over results obtained with these molecular imaging modalities so far.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ARVC/D:
-
Arrhythmogenic right ventricular cardiomyopathy/dysplasia
- ARVD/C:
-
Arrhythmogenic right ventricular dysplasia/cardiomyopathy
- BS:
-
Brugada syndrome
- DCM:
-
Dilated cardiomyopathy
- ECG:
-
Electrocardiogram
- EP:
-
Electrophysiological
- HCM:
-
Hypertrophic cardiomyopathy
- HMR:
-
Heart-to-mediastinum ratio
- ICD:
-
Implantable cardioverter–defibrillator
- ILVT:
-
Idiopathic left ventricular tachycardia
- IVF:
-
Idiopathic ventricular fibrillation
- IVT:
-
Idiopathic ventricular tachycardias
- LQTS:
-
Long QT syndrome
- LV:
-
Left ventricle
- LVEF:
-
Left ventricular ejection fraction
- MQNB:
-
Methylquinuclidinylbenzilat
- PET:
-
Positron-emission tomography
- RVOT:
-
Right ventricular outflow tract tachycardia
- SPECT:
-
Single-photon emission computed tomography
- VF:
-
Ventricular fibrillation
- VT:
-
Ventricular tachycardia
References
Ackerman MJ, Priori SG, Willems S et al (2011) HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Europace 13:1077–1109
Agostini D, Scanu P, Loiselet P et al (1998) Iodine-123-metaiodobenzylguanidine SPECT of regional cardiac adrenergic denervation in Brugada syndrome. J Nucl Med 39:1129–1132
Barsheshet A, Brenyo A, Moss AJ et al (2011) Genetics of sudden cardiac death. Curr Cardiol Rep 13:364–376
Bax JJ, Kraft O, Buxton AE et al (2008) 123 I-mIBG scintigraphy to predict inducibility of ventricular arrhythmias on cardiac electrophysiology testing: a prospective multicenter pilot study. Circ Cardiovasc Imaging 1:131–140
Berne P, Brugada J (2012) Brugada syndrome 2012. Circ J 76:1563–1571
Boogers MJ, Borleffs CJ, Henneman MM et al (2010) Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients. J Am Coll Cardiol 55:2769–2777
Brugada P, Brugada J (1992) Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 20:1391–1396
Chevalier P, Rodriguez C, Bontemps L et al (2001) Non-invasive testing of acquired long QT syndrome: evidence for multiple arrhythmogenic substrates. Cardiovasc Res 50:386–398
Fuster V, Gersh BJ, Giuliani ER et al (1981) The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 47:525–531
Gill JS, Hunter GJ, Gane J et al (1993) Asymmetry of cardiac [123I] meta-iodobenzyl-guanidine scans in patients with ventricular tachycardia and a “clinically normal” heart. Br Heart J 69:6–13
Göhl K, Feistel H, Weikl A et al (1991) Congenital myocardial sympathetic dysinnervation (CMSD)–a structural defect of idiopathic long QT syndrome. Pacing Clin Electrophysiol 14:1544–1553
Henderson EB, Kahn JK, Corbett JR et al (1988) Abnormal I-123 myocardial metaiodobenzylguanidine washout and distribution may reflect myocardial adrenergic derangement in patients with congestive heart cardiomyopathy. Circulation 78:1192–1199
Hobbs JB, Peterson DR, Moss AJ et al (2006) Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. JAMA 296:1249–1254
Isobe S, Izawa H, Iwase M et al (2005) Cardiac 123I-MIBG reflects left ventricular functional reserve in patients with nonobstructive hypertrophic cardiomyopathy. J Nucl Med 46:909–916
John RM, Tedrow UB, Koplan BA et al (2012) Ventricular arrhythmias and sudden cardiac death. Lancet 380:1520–1529
Kawaguchi T, Nomura M, Tujikawa T et al (2006) 123I-metaiodo-benzylguanidine myocardial scintigraphy in the Brugada-type ECG. J Med Invest 53:95–102
Kelly DP, Strawss AW (1994) Inherited cardiomyopathies. N Engl J Med 330:913–919
Kies P, Wichter T, Schäfers M et al (2004) Abnormal myocardial presynaptic norepinephrine recycling in patients with Brugada syndrome. Circulation 110:3017–3022
Kies P, Paul M, Gerss J et al (2011) Impaired cardiac sympathetic innervation in symptomatic patients with long QT syndrome. Eur J Nucl Med Mol Imaging 38:1899–1907
Kim RJ, Iwai S, Markowitz SM et al (2007) Clinical and electrophysiological spectrum of idiopathic ventricular outflow tract arrhythmias. J Am Coll Cardiol 49:2035–2043
Kostopoulou A, Koutelou M, Theodorakis G et al (2010) Disorders of the autonomic nervous system in patients with Brugada syndrome: a pilot study. J Cardiovasc Electrophysiol 21:773–780
Lemery R, Brugada P, Bella PD et al (1989) Nonischemic ventricular tachycardia: clinical course and long-term follow-up in patients without clinically overt heart disease. Circulation 79:990–999
Maeno M, Ishida Y, Shimonagata T et al (1993) The significance of 201Tl/123I MIBG (metaiodobenzylguanidine) mismatched myocardial regions for predicting ventricular tachycardia in patients with idiopathic dilated cardiomyopathy. Kaku Igaku 30:1221–1229
Marcus FI, Fontaine GH, Guiraudon G et al (1982) Right ventricular dysplasia: a report of 24 cases. Circulation 65:384–398
Maron BJ, Doerer JJ, Haas TS et al (2009) Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980–2006. Circulation 119:1085–1092
Matsuo S, Nakamura Y, Tsutamoto T et al (2002) Impairments of myocardial sympathetic activity may reflect the progression of myocardial damage or dysfunction in hypertrophic cardiomyopathy. J Nucl Cardiol 9:407–412
Mazzadi AN, André-Fouët X, Duisit J et al (2003) Cardiac retention of [11C]HED in genotyped long QT patients: a potential amplifier role for severity of the disease. Am J Physiol Heart Circ Physiol 285:1286–1293
Mitrani RD, Klein LS, Miles WM et al (1993) Regional cardiac sympathetic denervation in patients with ventricular tachycardia in the absence of coronary artery disease. J Am Coll Cardiol 22:1344–1353
Momose M, Kobayashi H, Kasanuki H et al (1998) Evaluation of regional cardiac sympathetic innervation in congenital long QT syndrome using 123I-MIBG scintigraphy. Nucl Med Commun 19:943–951
Morita H, Wu J, Zipes DP (2008) The QT syndromes: long and short. Lancet 372:750–763
Müller KD, Jakob H, Neuzner J et al (1993) 123I-metaiodobenzylguanidine scintigraphy in the detection of irregular regional sympathetic innervation in long QT syndrome. Eur Heart J 14:316–325
Nakagawa M, Takahashi N, Nobe S et al (2002) Gender differences in various types of idiopathic ventricular tachycardia. J Cardiovasc Electrophysiol 13:633–638
Ohshima S, Isobe S, Izawa H et al (2005) Cardiac sympathetic dysfunction correlates with abnormal myocardial contractile reserve in dilated cardiomyopathy patients. J Am Coll Cardiol 46:2061–2068
Ohshima S, Isobe S, Hayashi D et al (2013) Myocardial (123)I-MIBG scintigraphy predicts an impairment in myocardial functional reserve during dobutamine stress in patients with idiopathic dilated cardiomyopathy. Eur J Nucl Med Mol Imaging 40:262–270
Oyama N, Oyama N, Yokoshiki H et al (2002) Iodine-123-metaiodobenzylguanidine scintigraphy of total cardiac adrenergic denervation in Brugada syndrome. Jpn Heart J 43:183–186
Paul M, Schäfers M, Kies P et al (2006) Impact of sympathetic innervation on recurrent life-threatening arrhythmias in the follow-up of patients with idiopathic ventricular fibrillation. Eur J Nucl Med Mol Imaging 33:866–870
Paul M, Wichter T, Kies P et al (2011) Cardiac sympathetic dysfunction in genotyped patients with arrhythmogenic right ventricular cardiomyopathy and risk of recurrent ventricular tachyarrhythmias. J Nucl Med 52:1559–1565
Roden DM (2008) Clinical practice: long-QT syndrome. N Engl J Med 358:169–176
Sasano T, Abraham MR, Chang KC et al (2008) Abnormal sympathetic innervation of viable myocardium and the substrate of ventricular tachycardia after myocardial infarction. J Am Coll Cardiol 51:2266–2275
Schäfers M, Lerch H, Wichter T et al (1998) Cardiac sympathetic innervation in patients with idiopathic right ventricular outflow tract tachycardia. J Am Coll Cardiol 32:181–186
Schäfers M, Wichter T, Lerch H et al (1999) Cardiac 123I-MIBG uptake in idiopathic ventricular tachycardia and fibrillation. J Nucl Med 40:1–5
Sen-Chowdhry S, Morgan RD, Chambers JC et al (2010) Arrhythmogenic cardiomyopathy: etiology, diagnosis, and treatment. Annu Rev Med 61:233–253
Survivors of out-of-hospital cardiac arrest with apparently normal heart. Need for definition and standardized clinical evaluation. Consensus Statement of the Joint Steering Committees of the Unexplained Cardiac Arrest Registry of Europe and of the Idiopathic Ventricular Fibrillation Registry of the United States (1997). Circulation 95:265–272
Terai H, Shimizu M, Ino H et al (2003) Changes in cardiac sympathetic nerve innervation and activity in pathophysiologic transition from typical to end-stage hypertrophic cardiomyopathy. J Nucl Med 44:1612–1617
Wakabayashi T, Nakata T, Hashimoto A et al (2001) Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death. J Nucl Med 42:1757–1767
Wichter T, Hindricks G, Lerch H et al (1994) Regional myocardial sympathetic dysinnervation in arrhythmogenic right ventricular cardiomyopathy. An analysis using 123I-meta-iodobenzylguanidine scintigraphy. Circulation 89:667–683
Wichter T, Schäfers M, Rhodes CG et al (2000) Abnormalities of cardiac sympathetic innervation in arrhythmogenic right ventricular cardiomyopathy: quantitative assessment of presynaptic norepinephrine reuptake and postsynaptic beta-adrenergic receptor density with positron emission tomography. Circulation 101:1552–1558
Wichter T, Matheja P, Eckardt L et al (2002) Cardiac autonomic dysfunction in Brugada syndrome. Circulation 105:702–706
Yamanari H, Nakayama K, Morita H et al (2000) Effects of cardiac sympathetic innervation on regional wall motion abnormality in patients with long QT syndrome. Heart 83:295–300
Yoshimura N, Kimura M, Ozaki T et al (1998) Two patients with hypertrophic cardiomyopathy showing regionally increased washout of 123I-MIBG from the thick myocardium. Kaku Igaku 35:315–320
Zhao C, Shuke N, Yamamoto W et al (2001) Comparison of cardiac sympathetic nervous function with left ventricular function and perfusion in cardiomyopathies by (123)I-MIBG SPECT and (99m)Tc-tetrofosmin electrocardiographically gated SPECT. J Nucl Med 42:1017–1024
Zipes DP (1991) Sympathetic stimulation and arrhythmias. N Engl J Med 325:656–657
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Vrachimis, A., Schäfers, M., Stegger, L., Wenning, C. (2015). Autonomic Imaging in Ventricular Arrhythmias. In: Slart, R., Tio, R., Elsinga, P., Schwaiger, M. (eds) Autonomic Innervation of the Heart. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45074-1_18
Download citation
DOI: https://doi.org/10.1007/978-3-662-45074-1_18
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-45073-4
Online ISBN: 978-3-662-45074-1
eBook Packages: MedicineMedicine (R0)